期刊文献+

接纳与承诺疗法心理干预对原发性肝癌患者负性情绪和治疗依从性的影响

The effects of acceptance and commitment therapy psychological intervention on negative emotion and treatment compliance of patients with primary liver cancer
下载PDF
导出
摘要 目的:探讨接纳与承诺疗法(acceptance and commitment therapy,ACT)心理干预对原发性肝癌患者负性情绪和治疗依从性的影响。方法:选取2019年5月至2021年4月咸阳市中心医院收治的100例原发性肝癌患者进行前瞻性研究。按照入院时间顺序编号采用随机数字表法将100例患者分为干预组和对照组各50例。对照组患者给予常规心理护理,干预组患者在常规心理护理基础上实施ACT心理干预。比较两组患者治疗依从性,以及护理后抑郁自评量表(depression self-evaluation schedule,SDS)、焦虑自评量表(anxiety and self-evaluation scale,SAS)评分。结果:干预组患者治疗依从性高于对照组患者[96.0%(48/50)比78.0%(39/50)],且差异有统计学意义(χ^(2)=5.315,P<0.05)。护理后干预组患者SDS评分、SAS评分均低于对照组患者[(49.3±1.7)分比(53.0±1.6)分,(44.2±1.5)分比(48.9±1.5)分],且差异均有统计学意义(t=11.525、15.969,P均<0.001)。结论:应用ACT进行心理干预,可减少原发性肝癌患者负性情绪,提高其治疗依从性,改善患者心理压力,从而提高患者的生活质量。 Objective:To investigate the effects of acceptance and commitment therapy(ACT)psychological intervention on negative emotion and treatment compliance of patients with primary liver cancer.Method:Totally 100 patients were choose with primary liver cancer in our department for the observation object from May 2019 to April 2021.According to the admission time order using a random digital table to divide the patient into 50 cases of intervention group and control group.And the control group were given conventional care,intervention group implements ACT psychological intervention on the basis of regular care.Compared the results of the two groups.Result:Anxiety and self-evaluation scale(SAS)rating/depression self-evaluation schedule(SDS)score of the intervention group is lower than that of the control group[96.0%(48/50)vs 78.0%(39/50),χ^(2)=5.315,P<0.05].The treatment compliance of the intervention group was higher than that of the control group[(49.3±1.7)vs(53.0±1.6),t=11.525,P<0.001;(44.2±1.5)vs(48.9±1.5),t=15.969,P<0.001].Conclusion:Application of ACT psychological intervention,can reduce negative emotion of patients with primary liver cancer to improve their treatment compliance,reduce patient psychological pressure,thereby improving the survival quality of patients.
作者 孙亚莉 同欢庆 袁泼棉 刘乐 吴娜 周侃 翟九玲 Sun Yali;Tong Huanqing;Yuan Pomian;Liu Le;Wu Na;Zhou Kan;Zhai Jiuling(Department of Hepatobiliary Surgery,Xianyang Central Hospital,Xianyang 712000,Shaanxi,China)
出处 《肝癌电子杂志》 2024年第1期38-41,共4页 Electronic Journal of Liver Tumor
关键词 接纳与承诺疗法 原发性肝癌 负性情绪 治疗依从性 Acceptance and commitment therapy Primary liver cancer Negative emotion Treatment compliance
  • 相关文献

参考文献11

二级参考文献188

  • 1方蕾,崔宇红,许瑞,李芳,吉秀家.慢性病患者医学应对方式与风险感知的关系及其相关因素分析[J].慢性病学杂志,2020(12):1792-1797. 被引量:6
  • 2Saleh Daher,Muhammad Massarwa,Ariel A. Benson,Tawfik Khoury.Current and Future Treatment of Hepatocellular Carcinoma:An Updated Comprehensive Review[J].Journal of Clinical and Translational Hepatology,2018,6(1):69-78. 被引量:34
  • 3Yao, Deng-Fu,Dong, Zhi-Zhen,Yao, Min.Specific molecular markers in hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2007,6(3):241-247. 被引量:55
  • 4Jian-Yong Lei,Wen-Tao Wang,Lu-Nan Yan.Up-to-seven criteria for hepatocellular carcinoma liver transplantation:A single center analysis[J].World Journal of Gastroenterology,2013,19(36):6077-6083. 被引量:9
  • 5Masami Minagawa,Masatoshi Makuuchi.Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus[J].World Journal of Gastroenterology,2006,12(47):7561-7567. 被引量:78
  • 6Alexander J. Thompson,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric J. Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg W. Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem H. Ghalib,Bradley Freilich,Lisa M. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David B. Goldstein,John G. McHutchison.Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus[J]. Gastroenterology . 2010 (1)
  • 7Josep M. Llovet,Jordi Bruix.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology . 2003 (2)
  • 8Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
  • 9Shukui Qin,Yuxian Bai,Ho Yeong Lim,Sumitra Thongprasert,Yee Chao,Jia Fan,Tsai-Shen Yang,Vajarabhongsa Bhudhisawasdi,Won Ki Kang,Yu Zhou,Jee Hyun Lee,Yan Sun.Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia[J].Journal of Clinical Oncology.2013(28)
  • 10Stephen L. Chan,Frankie K. F. Mo,Cesar S. C. Wong,Charles M. L. Chan,Linda K. S. Leung,Edwin P. Hui,Brigette B. Ma,Anthony T. C. Chan,Tony S. K. Mok,Winnie Yeo.A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma[J].Cancer.2011(16)

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部